8-K: Elanco Animal Health Holds 2025 Annual Meeting, Elects Directors and Ratifies Auditor

Elanco Animal Health Incorporated held its annual shareholder meeting on May 16, 2025, where directors were elected, the appointment of Ernst & Young LLP was ratified, and executive compensation was approved in a non-binding vote.

Summary

• Elanco Animal Health Incorporated held its annual meeting of shareholders on May 16, 2025.
• All director nominees were elected for a one-year term ending at the 2026 annual meeting.
• Kapila K. Anand received 300,900,004 votes for, 156,032,826 against, and 208,081 abstentions.
• Paul Herendeen received 432,060,248 votes for, 24,992,504 against, and 88,159 abstentions.
• The appointment of Ernst & Young LLP as the independent registered public accounting firm for 2025 was ratified.
• 470,067,158 votes were cast for, 3,077,086 against, and 173,479 abstained.
• Shareholders approved, in a non-binding vote, the compensation of Elanco's named executive officers.
• 244,532,049 votes were cast for, 212,491,837 against, and 117,025 abstained.
• Shareholders approved, in a non-binding vote, every one year as the frequency with which shareholders vote on executive compensation.
• 434,846,332 votes were cast for 1 year, 342,872 for 2 years, 21,735,091 for 3 years, and 216,616 abstained.
• The company will conduct an advisory vote on executive compensation annually until the next required frequency vote, which will occur no later than the company's 2031 annual meeting of shareholders.

Sentiment

Score: 7

Explanation: The document presents routine corporate governance matters with generally positive outcomes (election of directors, ratification of auditor). The sentiment is neutral to slightly positive.

Positives

• All director nominees were successfully elected.
• The appointment of the independent accounting firm was ratified.
• Shareholders approved the executive compensation package.
• The decision to hold annual advisory votes on executive compensation provides shareholders with regular input.

Future Outlook

The company will conduct an advisory vote on executive compensation annually until the next required frequency vote, which will occur no later than the company's 2031 annual meeting of shareholders.

Industry Context

This announcement is a routine disclosure following an annual shareholder meeting, which is standard practice for publicly traded companies. It provides transparency to investors regarding the election of directors, auditor ratification, and executive compensation.

Stakeholder Impact

• Shareholders have elected directors to represent their interests.
• Shareholders have ratified the appointment of the company's auditor.
• Shareholders have provided input on executive compensation.

Key Dates

Keywords

Annual Meeting, Shareholders, Elanco, Directors, Executive Compensation, Ernst & Young, Voting Results